Diagnostic spectrum and time intervals in Sweden’s first diagnostic center for patients with nonspecific symptoms of cancer

References

• Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284.
   PubMed Web of Science ®Google Scholar
• Neal RD, Tharmanathan P, France B, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015;112: S92–S107.
   PubMed Web of Science ®Google Scholar
• Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–1126.
   PubMed Web of Science ®Google Scholar
• Rutqvist LE. Waiting times for cancer patients–a "slippery slope" in oncology. Acta Oncol. 2006;45:121–123.
   PubMed Web of Science ®Google Scholar
• Torring ML, Frydenberg M, Hansen RP, et al. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer. 2013;49:2187–2198.
   PubMed Web of Science ®Google Scholar
• Moller H, Gildea C, Meechan D, et al. Use of the English urgent referral pathway for suspected cancer and mortality in patients with cancer: cohort study. BMJ. 2015;351:h5102.
   PubMed Web of Science ®Google Scholar
• MacArtney J, Malmstrom M, Overgaard Nielsen T, et al. Patients' initial steps to cancer diagnosis in Denmark, England and Sweden: what can a qualitative, cross-country comparison of narrative interviews tell us about potentially modifiable factors? BMJ Open. 2017;7:e018210.
   PubMed Web of Science ®Google Scholar
• Department of Health. The NHS Cancer Plan. A Plan for Investment, a Plan for Reform. London, UK.: Department of Health; 2000.
   Google Scholar
• Gilstad H. Online Information about Cancer Patient Pathways (CPP) in Norway. eTELEMED 2016: The Eighth International Conference on eHealth, Telemedicine, and Social Medicine; Venice, Italy 2016.
   Google Scholar
• Vedsted P, Olesen F. A differentiated approach to referrals from general practice to support early cancer diagnosis - the Danish three-legged strategy. Br J Cancer. 2015;112:S65–S69.
   PubMed Web of Science ®Google Scholar
• Allemani C, Matsuda T, DiCarlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127–138.
   PubMed Web of Science ®Google Scholar
• Björnberg A. Euro Health Consumer Index 2017. In: Health Consumer Powerhouse Ltd., editor. 2018.
   Google Scholar
• The National Board of Health and Welfare. Standardiserade vårdförlopp i cancervården. Lägesrapport 2017 [Standardized care pathways in cancer care. Progress report 2017]. Stockholm, Sweden: The National Board of Health and Welfare; 2017.
   Google Scholar
• Ingebrigtsen SG, Scheel BI, Hart B, et al. Frequency of 'warning signs of cancer' in Norwegian general practice, with prospective recording of subsequent cancer. Fam Pract. 2013;30:153–160.
   PubMed Web of Science ®Google Scholar
• Jensen H, Torring ML, Olesen F, et al. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14:636.
   Web of Science ®Google Scholar
• Nielsen TN, Hansen RP, Vedsted P. [Symptom presentation in cancer patients in general practice]. Ugeskr Laeg. 2010;172:2827–2831.
   PubMedGoogle Scholar
• Zhou Y, Mendonca SC, Abel GA, et al. Variation in 'fast-track' referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites. Br J Cancer. 2018;118:24–31.
   PubMed Web of Science ®Google Scholar
• Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101:S80–S86.
   PubMed Web of Science ®Google Scholar
• Bislev LS, Bruun BJ, Gregersen S, et al. Prevalence of cancer in Danish patients referred to a fast-track diagnostic pathway is substantial. Danish Medical J. 2015;62(9):A5138.
   Web of Science ®Google Scholar
• Ingeman ML, Christensen MB, Bro F, et al. The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability. BMC Cancer. 2015;15:421.
   PubMed Web of Science ®Google Scholar
• Nicholson BD, Oke J, Friedemann Smith C, et al. The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer. BMJ Open. 2018;8:e018168.
   PubMed Web of Science ®Google Scholar
• The National Board of Health Copenhagen. Diagnostisk pakkeforløb for patienter med uspecifikke symptomer på alvorlig sygdom, der kunne vaere kraeft [Diagnostic pathway for patients with non-specific symptoms of serious illness that might be cancer]. Second ed 2012, Copenhagen, Denmark.
   Google Scholar
• Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106:1262–1267.
   PubMed Web of Science ®Google Scholar
• Naeser E, Fredberg U, Møller H, et al. Clinical characteristics and risk of serious disease in patients referred to a diagnostic centre: A cohort study. Cancer Epidemiol. 2017;50:158–165.
   PubMed Web of Science ®Google Scholar
• Donker GA, Wiersma E, van der Hoek L, et al. Determinants of general practitioner's cancer-related gut feelings-a prospective cohort study. BMJ Open. 2016;6:e012511.
   PubMed Web of Science ®Google Scholar
• Holtedahl K, Vedsted P, Borgquist L, et al. Abdominal symptoms in general practice: Frequency, cancer suspicions raised, and actions taken by GPs in six European countries. Cohort study with prospective registration of cancer. Heliyon 2017;3:e00328.
   PubMed Web of Science ®Google Scholar
• Ewing M, Naredi P, Nemes S, et al. Increased consultation frequency in primary care, a risk marker for cancer: a case-control study. Scand J Prim Health Care. 2016;34:205–212.
   PubMed Web of Science ®Google Scholar
• Hansen PL, Hjertholm P, Vedsted P. Increased diagnostic activity in general practice during the year preceding colorectal cancer diagnosis. Int J Cancer. 2015;137:615–624.
   PubMed Web of Science ®Google Scholar
• Naeser E, Møller H, Fredberg U, et al. Routine blood tests and probability of cancer in patients referred with non-specific serious symptoms: a cohort study. BMC Cancer. 2017;17:817.
   PubMed Web of Science ®Google Scholar